[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-661993-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-661993-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","biofire-blood-culture-identification-2-bcid2-panel-instructions-for-use","BIOFIRE Blood Culture Identification 2 (BCID2) Panel - Instructions for Use","","BIOFIRE Blood Culture Identification 2 (BCID2) Panel instructions describe a multiplexed nucleic acid test for qualitative simultaneous detection and identification of multiple bacterial and yeast targets and select antimicrobial resistance determinants. The panel is run directly on blood culture samples flagged positive by continuous monitoring systems and results are interpreted alongside Gram stain. It identifies specified organism types and includes assays for resistance genes such as mecA/C, vanA/vanB, CTX-M, KPC, NDM, OXA-48-like, VIM and mcr-1, with guidance that negative results do not confirm susceptibility.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/biofire-blood-culture-identification-2-bcid2-panel-instructions-for-use/661993/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/biofire-blood-culture-identification-2-bcid2-panel-instructions-for-use/661993.png","ImageObject",300,407,{"name":42,"@type":43},"Mimi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-10-28",true,{"@type":52,"interactionType":53,"userInteractionCount":22},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is the intended use of the BIOFIRE BCID2 Panel?","Question",{"text":62,"@type":63},"It is a multiplexed nucleic acid test for simultaneous qualitative detection and identification of multiple bacterial and yeast nucleic acids and select antimicrobial resistance genetic determinants using positive blood culture samples.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How should BCID2 Panel results be interpreted?",{"text":67,"@type":63},"Results are intended to be interpreted together with Gram stain results and other clinical and laboratory findings. Positive results do not exclude co-infection with organisms not included in the panel.",{"name":69,"@type":60,"acceptedAnswer":70},"Does a negative resistance-gene result mean the organism is susceptible?",{"text":71,"@type":63},"No. Negative results for select antimicrobial resistance gene and marker assays do not indicate susceptibility because multiple resistance mechanisms may exist.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},661993,1793193135,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,109,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":107,"slug":108},7,40,"healthcare",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},8,"Research & Report",30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":106,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":22,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":79,"read_time":144},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","BIOFIRE® Blood Culture Identification 2 (BCID2) Panel  \n| Instructions for Use | [https://www.biofiredx.com/e-labeling/ITI0048](https://www.biofiredx.com/e-labeling/ITI0048) |\n| --- | --- |\n| Quick Guide | [https://www.biofiredx.com/e-labeling/ITI0068](https://www.biofiredx.com/e-labeling/ITI0068) |\n| Safety Data Sheet (SDS) | [https://www.biofiredx.com/e-labeling/ITI0088](https://www.biofiredx.com/e-labeling/ITI0088) |\n| Panel Pouch Module Software | [https://www.biofiredx.com/e-labeling/ITIFA20BCID210](https://www.biofiredx.com/e-labeling/ITIFA20BCID210) |\n| Summary of Safety and Performance (Applicable for EU Customers) | [https://www.biofiredx.com/e-labeling/ITIBCID29954](https://www.biofiredx.com/e-labeling/ITIBCID29954) |\n\n| Customer and Technical Support Information\u003Cbr>*For more information on how to contact Customer and Technical Support, refer to Appendix B. | U.S. Customers | Phone: 1-800-735-6544 (toll free)\u003Cbr>E-mail: [BioFireSupport@biomerieux.com](BioFireSupport@biomerieux.com)\u003Cbr>[Website:](Website: www.biofiredx.com)[ ](Website: www.biofiredx.com)[www.biofiredx.com](Website: www.biofiredx.com) |\n| --- | --- | --- |\n|  | Outside of the U.S. | Contact the local bioMérieux sales\u003Cbr>representative or an authorized distributor |\n\nINTENDED PURPOSE  \nIntended Use  \nThe BIOFIRE® Blood Culture Identification 2 (BCID2) Panel is a multiplexed nucleic acid test intended for use with BIOFIRE® FILMARRAY® 2.0 or BIOFIRE® FILMARRAY® Torch Systems for the simultaneous qualitative detection and identification of multiple bacterial and yeast nucleic acids and select genetic determinants associated with antimicrobial resistance. The BIOFIRE BCID2 Panel test is performed directly on blood culture samples identified as positive by a continuous monitoring blood culture system. Results are intended to be interpreted in conjunction with Gram stain results. The following organism types and subtypes are identified using the BIOFIRE BCID2 Panel:  \n\n| Gram Positive Bacteria |  |  |\n| --- | --- | --- |\n| Enterococcus faecalis | Staphylococcus spp. | Streptococcus spp. |\n| Enterococcus faecium | Staphylococcus aureus | Streptococcus agalactiae (Group B) |\n| Listeria monocytogenes | Staphylococcus epidermidis Staphylococcus lugdunensis | Streptococcus pneumoniae\u003Cbr>Streptococcus pyogenes (Group A) |\n| Gram Negative Bacteria |  |  |\n| Acinetobacter calcoaceticus-baumannii complex Bacteroides fragilis\u003Cbr>Haemophilus influenzae\u003Cbr>Neisseria meningitidis (encapsulated) Pseudomonas aeruginosa Stenotrophomonas maltophilia |  | Enterobacterales\u003Cbr>Enterobacter cloacae complex Escherichia coli\u003Cbr>Klebsiella aerogenes\u003Cbr>Klebsiella oxytoca\u003Cbr>Klebsiella pneumoniae group Proteus spp.\u003Cbr>Salmonella spp.\u003Cbr>Serratia marcescens |\n| Yeast |  |  |\n| Candida albicans\u003Cbr>Candida auris | Candida krusei\u003Cbr>Candida parapsilosis | Cryptococcus neoformans/gattii |\n\nCandida glabrata Candida tropicalis  \nThe BIOFIRE BCID2 Panel contains assays for the detection of genetic determinants associated with resistance to methicillin (mecA/C and mecA/C in conjunction with MREJ), vancomycin ( vanA and vanB), ß-lactams including penicillins, cephalosporins, monobactams, and carbapenems (blaCTX-M, blaIMP, blaKPC, blaNDM, blaOXA48-like, blaVIM) to aid in the identification of potentially antimicrobial-resistant organisms in positive blood culture samples. In addition, the panel includes an assay for the detection of the mobilized genetic determinant mcr-1 , an emerging marker of public health importance. The antimicrobial resistance gene or marker detected may or may not be associated with the agent responsible for disease. Negative results for these select antimicrobial resistance gene and marker assays do not indicate susceptibility, as multiple mechanisms of resistance to methicillin, vancomycin, ß-lactams, and colistin exist.  \n\n| Antimicrobial Resistance Genes |  |  |  |  |\n| --- | --- | --- | --- | --- |\n| CTX-M | KPC | mecA/C | NDM | vanA/B |\n| IMP | mcr-1 | mecA/C and M","cbCaifwbiXPIuIgR","https://ap.wps.com/l/cbCaifwbiXPIuIgR","pdf",3168516,121,"English","# Intended Purpose\n## Intended Use\n## Intended User and Use Environment\n# Summary and Explanation of the Test\n## Bloodstream Infections (BSIs)","[{\"question\":\"What is the intended use of the BIOFIRE BCID2 Panel?\",\"answer\":\"It is a multiplexed nucleic acid test for simultaneous qualitative detection and identification of multiple bacterial and yeast nucleic acids and select antimicrobial resistance genetic determinants using positive blood culture samples.\"},{\"question\":\"How should BCID2 Panel results be interpreted?\",\"answer\":\"Results are intended to be interpreted together with Gram stain results and other clinical and laboratory findings. Positive results do not exclude co-infection with organisms not included in the panel.\"},{\"question\":\"Does a negative resistance-gene result mean the organism is susceptible?\",\"answer\":\"No. Negative results for select antimicrobial resistance gene and marker assays do not indicate susceptibility because multiple resistance mechanisms may exist.\"}]","BIOFIRE Blood Culture Identification 2 (BCID2) Panel - Instructions for Use | PDF",305]